Levofloxacin Injection, Solution
Product Images NDC 0143-9722

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Levofloxacin (NDC 0143-9722). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Levofloxacin Structure (Levofloxacin Injection In 5 Percent Dextrose 1)

Levofloxacin Structure (Levofloxacin Injection In 5 Percent Dextrose 1)
Chemical structure diagram of Levofloxacin showing its molecular composition including fluorine, nitrogen-containing rings, ketone, carboxyl group, and a water of hydration (1/2 H2O).*
FDA Label Image

Figure 2: Mean Levofloxacin Plasma Concentration Vs. Time Profile: 750 mg (Levofloxacin Injection In 5 Percent Dextrose 2)

Figure 2: Mean Levofloxacin Plasma Concentration Vs. Time Profile: 750 mg (Levofloxacin Injection In 5 Percent Dextrose 2)
A line graph comparing plasma concentration (µg/mL) over time (hours) for 750 mg Levofloxacin administered orally as a tablet versus intravenously by 90-minute infusion. The graph shows higher initial plasma levels with intravenous infusion and a gradual decline in concentration over 36 hours for both administration routes.*
FDA Label Image

Figure 3: Mean Levofloxacin Plasma Concentration Vs. Time Profile: 500 mg (Levofloxacin Injection In 5 Percent Dextrose 3)

Figure 3: Mean Levofloxacin Plasma Concentration Vs. Time Profile: 500 mg (Levofloxacin Injection In 5 Percent Dextrose 3)
A plasma concentration versus time graph comparing 500 mg doses of Levofloxacin administered orally (tablet) and intravenously (IV). The x-axis shows time in hours up to 36, and the y-axis shows plasma concentration in µg/mL, depicting the pharmacokinetic profile of both administration routes.*
FDA Label Image

To Open (TEAR AT NOTCH ONE UNIT LEVOFLOXACIN INJECTION in 5% Dextrose 250 mg in 50 mL 5% Dextrose (5 mg/mL) FOR INTRAVENOUS INFUSION INFUSE OVER 60 MINUTES LEAVE BAG IN OVERWRAP UNTIL USE. PHARMACIST: Dispense the accompanying Medication Guide to each patient. Each 50 mL contains a dilute solution equivalent of 250 mg of Levofloxacin, USP (5 mg/mL) in 5% dextrose. May contain Hydrochloric Acid, NF and/or Sodium Hydroxide, NF to adjust pH to 3.8-5.8. USUAL ADULT DOSAGE: See package insert. Recommended storage: at or below 25ºC (77ºF); however, brief exposure up to 40ºC (104ºF) does not adversely affect the product. Protect from light. Avoid excessive heat and protect from freezing. Single dose container. Additives should not be added or infused through the same intravenous line. The overwrap is a moisture barrier. Do not remove unit from overwrap until ready to use. Use unit promptly when pouch is open. After removing the overwrap, check for minute leaks by squeezing container firmly. If leaks are found, discard unit as sterility may be impaired. Use only if solution is clear and container is undamaged. DISCARD UNUSED PORTION. Must not be used in series connections. Rx Only NDC 0143-9722-01)

To Open (TEAR AT NOTCH ONE UNIT LEVOFLOXACIN INJECTION in 5% Dextrose 250 mg in 50 mL 5% Dextrose (5 mg/mL) FOR INTRAVENOUS INFUSION INFUSE OVER 60 MINUTES LEAVE BAG IN OVERWRAP UNTIL USE. PHARMACIST: Dispense the accompanying Medication Guide to each patient. Each 50 mL contains a dilute solution equivalent of 250 mg of Levofloxacin, USP (5 mg/mL) in 5% dextrose. May contain Hydrochloric Acid, NF and/or Sodium Hydroxide, NF to adjust pH to 3.8-5.8. USUAL ADULT DOSAGE: See package insert. Recommended storage: at or below 25ºC (77ºF); however, brief exposure up to 40ºC (104ºF) does not adversely affect the product. Protect from light. Avoid excessive heat and protect from freezing. Single dose container. Additives should not be added or infused through the same intravenous line. The overwrap is a moisture barrier. Do not remove unit from overwrap until ready to use. Use unit promptly when pouch is open. After removing the overwrap, check for minute leaks by squeezing container firmly. If leaks are found, discard unit as sterility may be impaired. Use only if solution is clear and container is undamaged. DISCARD UNUSED PORTION. Must not be used in series connections. Rx Only NDC 0143-9722-01)
Levofloxacin Injection 250 mg in 50 mL 5% Dextrose intravenous solution by Hikma Pharmaceuticals USA Inc. Label details dosage for intravenous infusion over 60 minutes and includes pharmacist instructions, storage conditions, and manufacturer information. The label instructs to leave the bag in the overwrap until use and warns to discard unused portions.*
FDA Label Image

To Open (TEAR AT NOTCH ONE UNIT LEVOFLOXACIN INJECTION in 5% Dextrose 500 mg in 100 mL 5% Dextrose (5 mg/mL) FOR INTRAVENOUS INFUSION INFUSE OVER 60 MINUTES LEAVE BAG IN OVERWRAP UNTIL USE. PHARMACIST: Dispense the accompanying Medication Guide to each patient. Each 100 mL contains a dilute solution equivalent of 500 mg of Levofloxacin, USP (5 mg/mL) in 5% dextrose. May contain Hydrochloric Acid, NF and/or Sodium Hydroxide, NF to adjust pH to 3.8-5.8. USUAL ADULT DOSAGE: See package insert. Recommended storage: at or below 25ºC (77ºF); however, brief exposure up to 40ºC (104ºF) does not adversely affect the product. Protect from light. Avoid excessive heat and protect from freezing. Single dose container. Additives should not be added or infused through the same intravenous line. The overwrap is a moisture barrier. Do not remove unit from overwrap until ready to use. Use unit promptly when pouch is open. After removing the overwrap, check for minute leaks by squeezing container firmly. If leaks are found, discard unit as sterility may be impaired. Use only if solution is clear and container is undamaged. DISCARD UNUSED PORTION. Must not be used in series connections. Rx Only NDC 0143-9721-01)

To Open (TEAR AT NOTCH ONE UNIT LEVOFLOXACIN INJECTION in 5% Dextrose 500 mg in 100 mL 5% Dextrose (5 mg/mL) FOR INTRAVENOUS INFUSION INFUSE OVER 60 MINUTES LEAVE BAG IN OVERWRAP UNTIL USE. PHARMACIST: Dispense the accompanying Medication Guide to each patient. Each 100 mL contains a dilute solution equivalent of 500 mg of Levofloxacin, USP (5 mg/mL) in 5% dextrose. May contain Hydrochloric Acid, NF and/or Sodium Hydroxide, NF to adjust pH to 3.8-5.8. USUAL ADULT DOSAGE: See package insert. Recommended storage: at or below 25ºC (77ºF); however, brief exposure up to 40ºC (104ºF) does not adversely affect the product. Protect from light. Avoid excessive heat and protect from freezing. Single dose container. Additives should not be added or infused through the same intravenous line. The overwrap is a moisture barrier. Do not remove unit from overwrap until ready to use. Use unit promptly when pouch is open. After removing the overwrap, check for minute leaks by squeezing container firmly. If leaks are found, discard unit as sterility may be impaired. Use only if solution is clear and container is undamaged. DISCARD UNUSED PORTION. Must not be used in series connections. Rx Only NDC 0143-9721-01)
Levofloxacin Injection 500 mg in 100 mL 5% Dextrose intravenous solution label. The label states dosage, infusion instructions to infuse over 60 minutes, storage recommendations, and cautions about handling and use. Manufactured by Hikma Farmaceutica (Portugal), distributed by West-Ward Pharmaceutical Corp., Eaton, NJ. Includes NDC 0143-9721-01, barcode, and space for lot and expiration date.*
FDA Label Image

To Open (TEAR AT NOTCH ONE UNIT LEVOFLOXACIN INJECTION in 5% Dextrose 750 mg in 150 mL 5% Dextrose (5 mg/mL) FOR INTRAVENOUS INFUSION INFUSE OVER 90 MINUTES LEAVE BAG IN OVERWRAP UNTIL USE. PHARMACIST: Dispense the accompanying Medication Guide to each patient. Each 150 mL contains a dilute solution equivalent of 750 mg of Levofloxacin, USP (5 mg/mL) in 5% dextrose. May contain Hydrochloric Acid, NF and/or Sodium Hydroxide, NF to adjust pH to 3.8-5.8. USUAL ADULT DOSAGE: See package insert. Recommended storage: at or below 25ºC (77ºF); however, brief exposure up to 40ºC (104ºF) does not adversely affect the product. Protect from light. Avoid excessive heat and protect from freezing. Single dose container. Additives should not be added or infused through the same intravenous line. The overwrap is a moisture barrier. Do not remove unit from overwrap until ready to use. Use unit promptly when pouch is open. After removing the overwrap, check for minute leaks by squeezing container firmly. If leaks are found, discard unit as sterility may be impaired. Use only if solution is clear and container is undamaged. DISCARD UNUSED PORTION. Must not be used in series connections. Rx Only NDC 0143-9720-01)

To Open (TEAR AT NOTCH ONE UNIT LEVOFLOXACIN INJECTION in 5% Dextrose 750 mg in 150 mL 5% Dextrose (5 mg/mL) FOR INTRAVENOUS INFUSION INFUSE OVER 90 MINUTES LEAVE BAG IN OVERWRAP UNTIL USE. PHARMACIST: Dispense the accompanying Medication Guide to each patient. Each 150 mL contains a dilute solution equivalent of 750 mg of Levofloxacin, USP (5 mg/mL) in 5% dextrose. May contain Hydrochloric Acid, NF and/or Sodium Hydroxide, NF to adjust pH to 3.8-5.8. USUAL ADULT DOSAGE: See package insert. Recommended storage: at or below 25ºC (77ºF); however, brief exposure up to 40ºC (104ºF) does not adversely affect the product. Protect from light. Avoid excessive heat and protect from freezing. Single dose container. Additives should not be added or infused through the same intravenous line. The overwrap is a moisture barrier. Do not remove unit from overwrap until ready to use. Use unit promptly when pouch is open. After removing the overwrap, check for minute leaks by squeezing container firmly. If leaks are found, discard unit as sterility may be impaired. Use only if solution is clear and container is undamaged. DISCARD UNUSED PORTION. Must not be used in series connections. Rx Only NDC 0143-9720-01)
Levofloxacin Injection in 5% Dextrose 750 mg in 150 mL solution for intravenous infusion. The label indicates usage instructions, storage conditions, and warnings, including that it is a single dose container and must be used promptly after opening. Labeler is Hikma Pharmaceuticals USA Inc.*
FDA Label Image

Levofloxacin Injection In 5 Percent Dextrose 7

Levofloxacin Injection In 5 Percent Dextrose 7
Levofloxacin injection, solution label from Hikma Pharmaceuticals USA Inc. The label shows a QR code beside text fields listing GTIN, serial number, expiration date, and lot number, indicating product traceability features.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.